Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Dongyuan Pharmacy Technology is a pharmaceutical manufacturer based in Guangzhou, China. The company was cited by the US FDA for significant violations of current good manufacturing practice regulations for finished pharmaceuticals as recently as 2019. The violations included inadequate process validation and lack of appropriate quality controls throughout product lifecycle management. There is no publicly available information on clinical trial results or innovative drug development programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Dongyuan Pharmacy Technology.